Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FPRN9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,886 to DMS Pharmaceutical Group Inc. for the supply of 68 milligram Nexplanon implants. The contract, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, operates under a firm fixed-price arrangement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility located in Park Ridge. This delivery order falls under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare needs.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts to provide branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's federal procurement history demonstrates expertise across diverse pharmaceutical categories, including contraceptive devices such as Nexplanon implants, oncology treatments, vaccines, and specialty medications. As a SAM.gov-registered small business since 2001, DMS Pharmaceutical Group leverages its woman-owned business status to compete effectively in federal procurement markets while fulfilling essential medical supply requirements for the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FPRN9?
SPE2DB25FPRN9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FPRN9 worth?
The government has obligated $13,886 on SPE2DB25FPRN9.
Is contract SPE2DB25FPRN9 an order under another contract?
Yes. SPE2DB25FPRN9 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRN9 competed?
The extent of competition for SPE2DB25FPRN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award